Dihydroergotamine

Any

Inj 1 mg per ml, 1 ml ampouleNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

Dihydroergotamine MesylateUnited States · 1MG/ML · injectable · Sagent Pharms INCSame form
D.H.E. 45United States · 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · BauschSame form
Dihydroergotamine (Dhe)Canada · 1 MG / ML · Solution · Sterimax INCSame substance
Migranal Nasal Spray 4MG/MLCanada · 0.5 MG / ACT · Liquid · Sterimax INCSame substance
Dihydroergotamine Mesylate Injection USPCanada · 1 MG / ML · Liquid · Sandoz Canada IncorporatedSame substance
DiidergotItaly · Compressa · Teofarma S.R.L.Same substance
DinezaItaly · Capsula rigida a rilascio modificato · D.M.G. Italia S.R.L.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dihydroergotamine

Any

Inj 1 mg per ml, 1 ml ampouleNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AtzumiUnited States · 5.2MG BASE · powder · Satsuma Pharms

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/HML/archive/2026/2026-10-01/HML_2026-10-01.xml; October 2026; published 2026-10-01; acquired 2026-10-13T22:49:54.923639+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dihydroergotamine
Dosage form: Inj 1 mg per ml, 1 ml ampoule
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Hospital Medicines List
Supply: Funded (PHARMAC)